In parallel, multi-omic analyses of lymphocytes from patients with MS and IBD have revealed context-dependent modulation of ITGA4, highlighting its dynamic role in immune cell trafficking and providing opportunities for precision-targeted integrin therapies (Demela et al., 2023; Mennillo et al., 2024). The gene discussed is ITGA4; the disease is myeloid sarcoma.